Kiora Capital Expenditures from 2010 to 2024
| KPRX Stock | USD 0.51 0.07 12.07% |
Capital Expenditures | First Reported 2013-03-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 16.9 K |
Check Kiora Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiora main balance sheet or income statement drivers, such as Depreciation And Amortization of 59.3 K, Selling General Administrative of 4.4 K or Other Operating Expenses of 10 M, as well as many exotic indicators such as Price To Sales Ratio of 1.8 K, Dividend Yield of 2.0E-4 or PTB Ratio of 0.43. Kiora financial statements analysis is a perfect complement when working with Kiora Pharmaceuticals Valuation or Volatility modules.
Kiora | Capital Expenditures |
Latest Kiora Pharmaceuticals' Capital Expenditures Growth Pattern
Below is the plot of the Capital Expenditures of Kiora Pharmaceuticals over the last few years. Capital Expenditures are funds used by Kiora Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Kiora Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Kiora Pharmaceuticals' Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kiora Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Capital Expenditures | 10 Years Trend |
|
Capital Expenditures |
| Timeline |
Kiora Capital Expenditures Regression Statistics
| Arithmetic Mean | 35,716 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 208.50 | |
| Mean Deviation | 48,239 | |
| Median | 0.00 | |
| Standard Deviation | 74,469 | |
| Sample Variance | 5.5B | |
| Range | 270K | |
| R-Value | 0.21 | |
| Mean Square Error | 5.7B | |
| R-Squared | 0.04 | |
| Significance | 0.46 | |
| Slope | 3,414 | |
| Total Sum of Squares | 77.6B |
Kiora Capital Expenditures History
About Kiora Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Kiora Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Kiora Pharmaceuticals investors use historical funamental indicators, such as Kiora Pharmaceuticals's Capital Expenditures, to determine how well the company is positioned to perform in the future. Although Kiora Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Kiora Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kiora Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Kiora Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Kiora Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Expenditures | 63.9 K | 0.0 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kiora Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kiora Pharmaceuticals' short interest history, or implied volatility extrapolated from Kiora Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Kiora Pharmaceuticals Correlation against competitors. For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Kiora Stock analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share 0.002 | Return On Assets (0.34) | Return On Equity (1.43) |
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiora Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.